Tilray Brands (TLRY) Payables (2017 - 2026)
Tilray Brands (TLRY) posted Payables of $232.8 million for Q1 2026, up 103.35% on a QoQ basis from $114.5 million in Q4 2025, and up 7.51% year-over-year from $216.6 million in Q1 2025.
Tilray Brands (TLRY) Payables (2017 - 2026) Analysis & Trends
Tilray Brands' Payables history runs 10 years deep, the most recent figure standing at $232.8 million for Q1 2026.
- Quarterly Payables rose 7.51% year-over-year to $232.8 million in Q1 2026, while the trailing twelve-month figure through Feb 2026 was $232.8 million (up 7.51% YoY) and the FY2025 annual result came in at $236.4 million, down 9.07% from the prior year.
- Payables was $232.8 million for Q1 2026 at Tilray Brands, up from $114.5 million in the prior quarter.
- Across five years, Payables topped out at $260.0 million in Q2 2024 and bottomed at $86.7 million in Q2 2022.
- A 5-year average of $170.4 million and a median of $181.5 million in 2023 frame the typical range for Payables.
- Annual changes were most pronounced in 2022 — Payables slumped 60.85% — and 2024, when it soared 171.77%.
- Tilray Brands' Payables stood at $88.4 million in 2022, then climbed by 22.79% to $108.5 million in 2023, then declined by 7.16% to $100.8 million in 2024, then gained by 13.62% to $114.5 million in 2025, then surged by 103.35% to $232.8 million in 2026.
- Business Quant data shows TLRY's Payables at $232.8 million in Q1 2026, $114.5 million in Q4 2025, and $235.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 4.96 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 2.60 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 731.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 3.13 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 498.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 8.82 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.75 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 773.00 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 372.00 Mn |
| 10 | Tilray Brands | 465.02 Mn | 373.06 Mn | 54.95 Mn | 232.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 232.83 Mn |
| Nov 30, 2025 | 114.50 Mn |
| Aug 31, 2025 | 235.68 Mn |
| May 31, 2025 | 236.41 Mn |
| Feb 28, 2025 | 216.57 Mn |
| Nov 30, 2024 | 100.77 Mn |
| Aug 31, 2024 | 254.28 Mn |
| May 31, 2024 | 259.99 Mn |
| Feb 29, 2024 | 224.79 Mn |
| Nov 30, 2023 | 108.54 Mn |
| Aug 31, 2023 | 93.57 Mn |
| May 31, 2023 | 214.06 Mn |
| Feb 28, 2023 | 181.55 Mn |
| Nov 30, 2022 | 88.40 Mn |
| Aug 31, 2022 | 94.12 Mn |
| May 31, 2022 | 86.73 Mn |
| Feb 28, 2022 | 154.59 Mn |
| Nov 30, 2021 | 177.04 Mn |
| Aug 31, 2021 | 199.42 Mn |
| May 31, 2021 | 221.53 Mn |